Research Papers:
LncRNA RSU1P2 contributes to tumorigenesis by acting as a ceRNA against let-7a in cervical cancer cells
PDF | HTML | Supplementary Files | How to cite
Metrics: PDF 3716 views | HTML 3198 views | ?
Abstract
Qian Liu1,*, Xu Guo1,*, Shengshun Que1,*, Xi Yang1, Hongxia Fan1, Min Liu1, Xin Li1 and Hua Tang1
1Tianjin Life Science Research Center, School of Basic Medical Sciences, Tianjin Medical University, Tianjin, China
*These authors have contributed equally to this work
Correspondence to:
Hua Tang, email: [email protected]
Keywords: ceRNA, miRNA, Let-7, N-myc, lnc-RNA
Received: December 13, 2015 Accepted: June 17, 2016 Published: July 26, 2016
ABSTRACT
Long non-coding RNAs (lncRNAs) can regulate gene expression at different levels and are widely participate in various physiological and pathological processes. Emerging evidences suggests that a number of differentially expressed lncRNAs are involved in tumorigenesis. However, the function and expression regulation of a vast majority of these unique RNAs is little known. Here, we found that the lncRNA Ras suppressor protein 1 pseudogene 2 (RSU1P2) is upregulateded in cervical cancer tissues and has a tumour-promoting role. We revealed that RSU1P2 acts as a competitive endogenous RNA (ceRNA) through regulating the expression of IGF1R, N-myc and EphA4. The mechanism of this regulation is via competition for the shared microRNA let-7a. This competition promotes the malignant phenotype of cervical carcinoma cells. The transcription factor N-myc forms a positive feedback loop with RSU1P2 by in turn activating its expression, thereby enhancing its oncogenic capacity. Hence, cancer-selective targeting of RSU1P2 could have strong benefits.
![Creative Commons License](/images/80x15.png)
PII: 10844